Skip to main content

FlowMax™ L-Citrulline

Sol

2,000 mg L-Citrulline

Form

Kyowa Quality® (≥99%)

Evidence

8+ Meta-Analyses

Effect

Cerebral + Cardiovascular Flow
The bioavailability breakthrough that makes arginine obsolete. For decades, L-Arginine was the go-to supplement for nitric oxide (NO) production — the master signaling molecule that dilates blood vessels, regulates blood pressure, and delivers oxygen and nutrients to every tissue including the brain. But there was a problem: oral arginine is extensively degraded by intestinal and hepatic arginase enzymes, with only ~20% reaching systemic circulation. Enter L-Citrulline — a non-protein amino acid that bypasses this first-pass metabolism entirely, achieving ~83% oral bioavailability and raising plasma arginine levels more effectively than arginine itself. The science is unequivocal: 3g of L-Citrulline produces a 227% increase in plasma arginine versus only 90% from an equivalent dose of L-Arginine. But the story doesn’t end at the periphery. L-Citrulline crosses the blood-brain barrier via the LAT1 transporter (expressed 187-fold higher than alternatives in brain capillaries), where it’s converted to L-Arginine to fuel neuronal nitric oxide synthase — the enzyme that couples neural activity to cerebral blood flow. This neurovascular coupling is fundamental to cognitive performance: every thought, every decision, every memory requires precisely-timed blood flow delivery. NTRPX uses Kyowa Quality® L-Citrulline — the gold-standard fermentation-derived ingredient used in the majority of published clinical trials. In Neuraldrink Sol, FlowMax™ L-Citrulline provides morning cerebral circulation support, synergizing with creatine and taurine to optimize both energy production and nutrient delivery to the brain.

Why Nitric Oxide Matters

Nitric oxide (NO) is arguably the most important signaling molecule in cardiovascular and neurological health:

The Discovery That Won a Nobel Prize

In 1998, Robert Furchgott, Louis Ignarro, and Ferid Murad were awarded the Nobel Prize in Physiology or Medicine for discovering nitric oxide’s role as a signaling molecule in the cardiovascular system. Their work revealed that NO:
DiscoveryImplication
Endothelium-derived relaxing factor = NOBlood vessels actively regulate their own diameter
NO activates guanylate cyclaseSmooth muscle relaxation via cGMP pathway
L-Arginine → NO via NOSAmino acid substrate identified
NO has ~5 second half-lifeContinuous production required

The Problem with Aging

NO production declines with age and cardiovascular risk factors:

Where L-Citrulline Fits

L-Citrulline addresses NO deficiency at its root — providing sustained substrate for NO synthesis:
PopulationNO StatusL-Citrulline Benefit
Healthy young adultsOptimalPerformance enhancement
Middle-aged adultsDecliningMaintenance/restoration
Older adultsCompromisedSignificant improvement
HypertensivesImpairedBlood pressure support
AthletesHigh demandRecovery & endurance
Key Insight: Unlike pharmaceutical NO donors (e.g., nitroglycerin), L-Citrulline provides substrate for endogenous NO production rather than exogenous NO. This means the body’s own regulatory mechanisms remain intact — NO is produced where and when needed, without tolerance development.
L-Citrulline’s superiority stems from its unique metabolic pathway:

The Bioavailability Advantage

Why L-Citrulline outperforms L-Arginine:
ParameterL-ArginineL-CitrullineWinner
Oral bioavailability~20%~83%L-Citrulline
First-pass metabolismExtensive (gut + liver arginase)MinimalL-Citrulline
Plasma arginine increase90% (at 3g)227% (at 3g)L-Citrulline
GI toleranceOsmotic diarrhea at high dosesExcellentL-Citrulline
Duration of effect2-3 hours4-6 hoursL-Citrulline
Dose equivalence3g L-Arg~1.5g L-CitL-Citrulline
Citation: Schwedhelm E, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine. Br J Clin Pharmacol. 2008;65(1):51-59. PMC2291275

The Citrulline-NO Cycle

A critical advantage: L-Citrulline is recycled during NO synthesis:This recycling means:
  • Sustained NO production from a single dose
  • Less arginine needed from dietary sources
  • Continuous substrate availability

NO Biomarker Evidence

Clinical proof that L-Citrulline increases NO production (Schwedhelm 2008):
ConditionL-Arginine/ADMA RatioUrinary Nitrate (μmol/mmol Cr)Urinary cGMP (nmol/mmol Cr)
Placebo186 ± 1192 ± 1238 ± 4.5
L-Citrulline 3g BID278 ± 14 (p<0.01)125 ± 15 (p=0.01)50 ± 6.7 (p=0.04)
BID = twice daily; ADMA = asymmetric dimethylarginine (endogenous NOS inhibitor); cGMP = cyclic GMP (NO second messenger)

Blood-Brain Barrier Transport

L-Citrulline reaches the brain via specific transporters:Citation: Lee NY, Kang YS. Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells). J Biomed Sci. 2017;24(1):28. PMC5387336

Transport Kinetics

ParameterValueSignificance
Km1 (high affinity)30.9 ± 1.0 μMActive at physiological concentrations
Km2 (low affinity)1.69 ± 0.43 mMCapacity for higher doses
Primary transporterLAT1Large amino acid transporter 1
Transport typeFacilitated diffusionIon-independent

Evidence Organization

Clinical studies are organized by outcome to clearly demonstrate L-Citrulline’s effects on brain blood flow and cognitive function.

Cerebral Blood Flow Studies

Landmark Animal Study: Neuroprotection (Yabuki 2013)

Citation: Yabuki Y, Shioda N, Yamamoto Y, et al. Oral L-citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection. Brain Res. 2013;1520:157-167.
Link: PubMed PMID: 23685189
ParameterDetail
ModelMouse bilateral common carotid artery occlusion (BCCAO)
InterventionL-Citrulline 50, 75, or 100 mg/kg p.o. for 10 days
Key FindingsPrevented neuronal cell death; prevented capillary loss in hippocampus
MechanismRestoration of eNOS expression
Significance: First demonstration that oral L-Citrulline provides cerebrovascular protection and cognitive preservation through eNOS restoration.

Human Trial: Cerebrovascular Recovery (2024)

Citation: The effects of L-citrulline supplementation on cerebrovascular function during sprint interval training in taekwondo athletes. PMC. 2024.
Link: PMC12137154
ParameterDetail
DesignDouble-blind, randomized, crossover
N20 male taekwondo athletes (18-30 years)
Intervention8.8g L-Citrulline vs. placebo × 5 days
Protocol4 × 30-second maximal sprints
AssessmentTranscranial Doppler (TCD)
Primary Outcomes:
MeasureL-CitrullinePlaceboInterpretation
ΔBHI (Breath-Holding Index)Recovery to baselineDeclinedAccelerated cerebrovascular recovery
ΔPI (Pulse Index)No differencePeripheral resistance unchanged
Key Finding: L-Citrulline specifically improved cerebral vascular recovery without affecting peripheral vascular resistance — suggesting targeted benefit for brain blood flow after intense exercise.

Mechanism Study: BBB Transport (Lee & Kang 2017)

Citation: Lee NY, Kang YS. Characteristics of L-citrulline transport through blood-brain barrier. J Biomed Sci. 2017;24(1):28.
Link: PMC5387336
FindingDetail
Transport confirmedL-Citrulline crosses BBB via LAT1
LAT1 expression187-fold higher than CAT1 in brain capillaries
KineticsTwo saturable components (Km1: 30.9 μM; Km2: 1.69 mM)
ImplicationBrain can convert L-Citrulline → L-Arginine → NO locally

Pilot Human Study: Mood & Cognition (Shafqat 2016)

Citation: Shafqat A. Citrulline and its effects on mood and cognitive function. Thesis. 2016.
ParameterDetail
DesignParallel group, placebo-controlled
N16 participants (8 young 18-35; 8 older 50+)
Intervention1.5g L-Citrulline daily vs. placebo × 4 weeks
OutcomesNO levels, pulse wave velocity, mood
Results:
OutcomeYoung GroupOlder GroupNotes
Pulse wave velocity↓ (p=0.032)↓ (p=0.030)Improved arterial compliance
NO levels↑ (p=0.018)↑ (p=0.004)Confirmed NO production
Mood disturbanceTrend ↓Trend ↓Non-significant improvement
Significance: Even at 1.5g/day (below typical doses), L-Citrulline improved vascular parameters in both age groups — suggesting low-dose maintenance benefits.

Blood Pressure Meta-Analyses

Two comprehensive meta-analyses confirm L-Citrulline’s antihypertensive effects:

Meta-Analysis 1: Barkhidarian 2019

Citation: Barkhidarian B, et al. Effects of L-citrulline supplementation on blood pressure: A systematic review and meta-analysis. Avicenna J Phytomed. 2019;9(1):10-20.
Link: PMC6369322
ParameterDetail
Studies included8 RCTs (10 data sets)
Total participants~200
Dose range3-6g/day
Duration range1-16 weeks
Overall Results:
OutcomeEffect Sizep-valueInterpretation
Systolic BP-4.1 mmHgp=0.037Significant reduction
Diastolic BP-2.1 mmHgp=0.17Non-significant overall
Subgroup Analysis (Diastolic BP by Dose):
DoseDBP Changep-value
<6g/day-1.5 mmHgNS
≥6g/day-2.75 mmHgp=0.04
Conclusion: Significant SBP reduction at all doses; significant DBP reduction requires ≥6g/day.

Meta-Analysis 2: Elderly Population (2025)

Citation: 2025 Meta-analysis on L-Citrulline in older adults (15 RCTs, n=415)
OutcomeEffect Size95% CIp-value
Systolic BP-4.0 mmHg[-6.5, -1.5]p=0.002
Diastolic BP-2.5 mmHg[-4.2, -0.8]p=0.004
Subgroup Findings:
FactorGreater EffectLesser Effect
Duration≥6 weeks<6 weeks
Baseline BPPre-hypertensive/HypertensiveNormotensive
AgeOlder adultsYounger adults

Individual Studies: Cardiovascular Outcomes

Angina Patients (Orozco-Gutiérrez 2010)

ParameterDetail
PopulationPatients with stable angina
Dose800 mg/day
Duration8 weeks
OutcomeImproved flow-mediated dilation (FMD)
Significance: Demonstrates vascular benefit at very low doses in compromised populations.

Heart Failure Patients (Balderas-Muñoz 2012)

ParameterDetail
PopulationHeart failure with preserved ejection fraction
Dose3g/day
Duration8 weeks
OutcomeImproved exercise tolerance; reduced fatigue

Blood Pressure Mechanism

Exercise Performance Studies

L-Citrulline has been extensively studied for exercise performance:

Cycling Performance (Suzuki 2016)

Citation: Suzuki T, et al. Oral L-citrulline supplementation enhances cycling time trial performance in healthy trained men. J Int Soc Sports Nutr. 2016;13:6.
Link: JISSN
ParameterDetail
DesignDouble-blind, randomized, placebo-controlled, crossover
N22 trained males
Intervention2.4g/day L-Citrulline × 7 days + 2.4g pre-exercise
Protocol4-km cycling time trial
Results:
OutcomeL-CitrullinePlacebop-value
Time to completionFasterp<0.05
Power/VO₂ ratioHigherp<0.05
Plasma NOxIncreasedp<0.05

High-Intensity Exercise (Bailey 2015)

Citation: Bailey SJ, et al. L-Citrulline supplementation improves O₂ uptake kinetics and high-intensity exercise performance in humans. J Appl Physiol. 2015;119(4):385-95.
Link: PubMed PMID: 26023227
ParameterDetail
DesignRandomized, placebo-controlled, crossover
N10 healthy adult men
Intervention6g/day L-Citrulline × 7 days
ProtocolModerate and severe-intensity cycling
Results:
OutcomeEffectSignificance
Severe-intensity tolerance+12%p<0.05
VO₂ kineticsFasterp<0.05
Blood pressureReducedp<0.05
Sprint work completed+7%p<0.05
Mechanism: Improved oxidative ATP production; reduced reliance on anaerobic metabolism.

Meta-Analysis: RPE & Muscle Soreness (Rhim 2020)

Citation: Rhim HC, et al. Effect of citrulline on post-exercise rating of perceived exertion, muscle soreness, and blood lactate levels: A systematic review and meta-analysis. J Sport Health Sci. 2020;9(6):553-561.
Link: PubMed PMID: 33308802
OutcomeEffectp-valueNotes
Rating of Perceived Exertion (RPE)Significantly ↓p<0.05Reduced perceived effort
Muscle SorenessSignificantly ↓p<0.05Faster recovery
Blood LactateNo significant changeNSNot a primary mechanism
Optimal Dosing for RPE Reduction: ≥3-4g L-Citrulline or 8g Citrulline Malate, taken 1 hour pre-exercise.

Performance Summary

OutcomeEvidence LevelEffective DoseTiming
Cycling time trialStrong2.4g/day × 7dPre-exercise
High-intensity toleranceStrong6g/day × 7dChronic
Perceived exertionModerate3-4g+1h pre-exercise
Muscle sorenessModerate3-4g+1h pre-exercise
Strength trainingMixed8g acute1h pre-exercise
Performance Context: Most performance studies use doses of 6-8g/day. At 2g/day (Neuraldrink Sol dose), the primary benefits are maintenance-level cardiovascular and cerebrovascular support rather than acute performance enhancement. For pre-workout performance, higher doses (6-8g) may be added.

Minimum Effective Doses by Application

ApplicationMinimum EffectiveOptimalEvidence Level
Plasma arginine elevation0.18g (doubles arginine)3gStrong
Vascular support (FMD)0.8g/day3g/dayModerate
Blood pressure (SBP)3g/day6g/dayStrong
Blood pressure (DBP)6g/day6g/dayStrong
Exercise performance2.4g/day6-8g/dayStrong
Cerebrovascular recoveryUnknown8.8g/dayLimited
Daily maintenance2-3g/day3g/daySupported

Pharmacokinetics

ParameterValueNotes
Tmax (plasma citrulline)0.5-1 hourRapid absorption
Tmax (plasma arginine)1-2 hoursDelayed conversion
Duration of arginine elevation4-6 hoursLonger than arginine
Steady-state benefits~7 daysChronic dosing
Elimination half-life~1 hour (citrulline)Short

Dose Selection Rationale: 2,000 mg

Why Not Higher in Sol?

DoseProCon
1gMinimalBelow most effective doses
2g✓ Meaningful maintenance benefitBelow acute performance dose
3gBetter BP effectsLarger powder volume
6gOptimal BP + performanceImpractical for drink format
Decision: 2,000 mg provides meaningful daily cardiovascular and cerebrovascular support while keeping the Neuraldrink Sol formula practical. Users seeking acute performance benefits can add additional L-Citrulline pre-workout.

The Combination Advantage

Research shows combining L-Citrulline and L-Arginine produces greater effects than either alone:Citation: Morita M, et al. Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration. Biosci Biotechnol Biochem. 2017;81(2):372-375.
Link: Oxford Academic

Plasma Arginine Response (1 Hour Post-Dose)

TreatmentPlasma Arginine IncreaseFold vs. Placebo
Placebo+5.4 μM
L-Citrulline 2g alone+66.3 μM12×
L-Arginine 2g alone+72.3 μM13×
L-Citrulline 1g + L-Arginine 1g+121.9 μM23×

Mechanism of Synergy

FactorL-Citrulline EffectSynergy Result
Arginase inhibitionL-Citrulline inhibits intestinal/hepatic arginaseL-Arginine protected from degradation
Dual substrateL-Citrulline converts to L-ArginineTwo sources of arginine
TimingL-Arginine peaks faster; L-Citrulline sustainsExtended arginine elevation

Future Consideration for Neuraldrink Sol

OptionProsCons
L-Citrulline 2g alone (current)Simple; well-studiedMay not maximize acute arginine
L-Citrulline 1.5g + L-Arginine 0.5gSynergy; potentially higher arginineMore ingredients; slightly higher cost
L-Citrulline 1g + L-Arginine 1gMaximum synergyReduces citrulline sustained effects
Future Optimization: The L-Citrulline + L-Arginine combination offers enhanced acute arginine elevation. A formula modification could add 500mg-1g L-Arginine to Neuraldrink Sol for potentiated effects, pending further formulation testing.

L-Citrulline vs. Citrulline Malate

ParameterL-CitrullineCitrulline Malate (2:1)
Citrulline content100%~56% by weight
Additional componentNoneMalic acid (~44%)
Dose equivalence2g L-Citrulline3.5g Citrulline Malate
TasteNeutralSlightly tart
Research baseStrongStrong
Best forPrecise dosing; neutral tastePerformance (malate may aid ATP)
NTRPX Decision: Pure L-Citrulline for precise dosing, neutral taste, and smaller powder volume.

L-Citrulline vs. Beetroot Nitrate

ParameterL-CitrullineBeetroot Nitrate
PathwayL-Arg → eNOS → NONO₃⁻ → NO₂⁻ → NO (bacterial)
ConsistencyHigh (standardized)Variable (oral bacteria dependent)
TasteNeutralEarthy, strong
ColorWhiteDeep red (staining)
Onset1-2 hours (arginine peak)2-3 hours (nitrite peak)
Antibiotics effectNoneAbolishes effect
Why L-Citrulline for Neuraldrink:
  • Neutral taste (critical for drink format)
  • No staining (beetroot causes red discoloration)
  • Consistent effect (doesn’t depend on oral microbiome)
  • Synergy with existing amino acids (creatine, taurine)

L-Citrulline vs. L-Arginine

ParameterL-CitrullineL-Arginine
Bioavailability~83%~20%
First-pass metabolismMinimalExtensive
Plasma arginine increase227% (at 3g)90% (at 3g)
GI toleranceExcellentOsmotic diarrhea at high doses
Research conclusionSuperiorLargely replaced
Verdict: L-Citrulline has effectively replaced L-Arginine as the preferred NO precursor in evidence-based formulations.

Natural Citrulline Sources

L-Citrulline is named after Citrullus lanatus — the watermelon:
FoodL-Citrulline ContentNotes
Watermelon (flesh)1.1-2.3 mg/gHighest natural source
Watermelon (rind)~2.0 mg/gHigher than flesh; usually discarded
Cucumber0.12-0.15 mg/gCucurbitaceae family
Bitter melon~0.05 mg/gAsian vegetable
SquashTraceCucurbitaceae family
PumpkinTraceCucurbitaceae family

The Dietary Gap

Food Equivalents for 2,000 mg L-Citrulline

FoodAmount NeededPractical?
Watermelon flesh~1 kg (2.2 lbs)⚠️ High sugar; seasonal
Watermelon rind~1 kg❌ Unpalatable
Cucumber~15 kg❌ Impractical

Why Supplementation Makes Sense

FactorDietarySupplement
Dose consistencyVariable by fruitStandardized 2,000 mg
Sugar contentHigh (watermelon)Zero
Year-round availabilitySeasonalAlways available
Cost per effective dose~$5/day (watermelon)~$0.20/day
ConvenienceRequires food prepIn morning drink
Clinical validationNone at dietary dosesMultiple RCTs

The Watermelon Tradition

Watermelon has been valued across cultures:
CultureTraditional Use
Ancient EgyptSeeds in King Tut’s tomb; valued for hydration
AfricaOriginated in Kalahari Desert; water storage
ChinaUsed in traditional medicine
Southern U.S.Summer hydration and refreshment
Dietary Recommendation: While consuming watermelon provides modest L-Citrulline along with lycopene and hydration, achieving therapeutic doses (2+ g/day) requires supplementation. Watermelon can be enjoyed for its other benefits without expecting significant vascular effects.

Adverse Event Profile

L-Citrulline has an exceptional safety record:
EventIncidenceSeverityNotes
GI discomfortVery rareMildSuperior to L-Arginine
HeadacheVery rareMildPossibly from vasodilation
FlushingVery rareMildVasodilation effect
HypotensionRare (dose-dependent)Mild-ModerateMore likely with PDE5 inhibitors

Safety Data

ParameterValueNotes
LD50Not determinableExtremely low toxicity
Maximum tested dose15g/dayNo adverse effects
GI toleranceExcellentNo osmotic diarrhea (unlike L-Arginine)
Chronic useWell-toleratedStudied up to 16 weeks
GRAS statusYesGenerally Recognized As Safe

Toxicity Comparison: L-Citrulline vs. L-Arginine

ParameterL-CitrullineL-Arginine
GI toleranceExcellentOsmotic diarrhea at >10g
Maximum tolerated dose>15g~10g
Hypotension riskLowModerate

Contraindications

ConditionConcernRecommendation
Active herpes infectionArginine may promote viral replicationCaution (theoretical)
HypotensionMay further lower BPUse with caution
PDE5 inhibitor useAdditive vasodilationAvoid concurrent use or consult physician
Pre-surgeryTheoretical bleeding/hypotensionDiscontinue 2 weeks prior

Drug Interactions

Drug ClassInteractionSeverityManagement
PDE5 inhibitors (sildenafil, tadalafil)Additive vasodilation/hypotensionModerateAvoid or reduce doses
AntihypertensivesAdditive BP reductionLow-ModerateMonitor; may enhance effect
Nitrates (nitroglycerin)Additive vasodilationModerateCaution; consult provider
AnticoagulantsTheoretical (NO affects platelets)LowMonitor

Special Populations

PopulationSafety StatusNotes
Healthy adultsWell-establishedPrimary study population
HypertensivesPositive dataMay enhance BP control
AthletesWell-establishedExtensive performance research
ElderlyPositive dataMultiple studies in older adults
PregnancyInsufficient dataNot recommended
LactationInsufficient dataCaution advised

Sleep Impact

AspectFinding
Direct sleep disruptionNo evidence at typical doses
Anecdotal reportsRare reports of poor sleep onset
MechanismPossible mild stimulation from improved blood flow
RecommendationMorning dosing preferred; avoid evening use in sensitive individuals

Regulatory Status

RegionStatus
United StatesGRAS (dietary supplement)
European UnionPermitted in food supplements
CanadaNatural Health Product
AustraliaListed substance
JapanFunctional food ingredient

Tier Classification

Tier 2: Supported

Efficacy

Moderate-High (BP, Cerebrovascular)

Validation

Strong — 8+ Meta-Analyses

Safety

Excellent — GRAS; >15g tested
Tier Rationale: Tier 2 (Supported) classification. L-Citrulline demonstrates consistent, clinically-meaningful benefits for blood pressure, vascular function, and cerebrovascular health across multiple meta-analyses. The bioavailability advantage over L-Arginine is well-established. Safety is excellent with GRAS status. Not Tier 1 (Foundation) because the primary applications are circulatory rather than foundational metabolic support, and cognitive benefits (while mechanistically supported) have less direct human trial data than cardiovascular outcomes.

Neuraldrink Sol Stack Integration

Creatine + L-Citrulline Synergy

Creatine FunctionL-Citrulline FunctionCombined Benefit
ATP regenerationBlood flow ↑Energy production + delivery
Phosphocreatine shuttleOxygen delivery ↑Efficient cellular respiration
Cognitive supportCerebral blood flow ↑Optimized brain metabolism
Muscle functionNutrient delivery ↑Enhanced physical performance
Synergy Mechanism: Creatine supports energy production, while L-Citrulline supports nutrient/oxygen delivery. Together, they ensure the brain and muscles have both the fuel and the blood flow to function optimally.

Taurine + L-Citrulline Synergy

Taurine FunctionL-Citrulline FunctionCombined Benefit
AntioxidantNO productionTaurine protects NO from oxidative degradation
Cardiovascular supportVasodilationComplementary CV mechanisms
OsmoregulationBlood flowOptimal cellular hydration + delivery
GABA modulationNo direct CNS effectTaurine calms; citrulline energizes (balance)
Key Insight: Taurine’s antioxidant properties help preserve nitric oxide bioavailability — NO is rapidly degraded by reactive oxygen species, and taurine reduces oxidative stress.

Vitamin C + L-Citrulline Synergy

Vitamin C FunctionL-Citrulline FunctionCombined Benefit
eNOS cofactor (BH4 recycling)eNOS substrate (via arginine)Both required for optimal NO synthesis
AntioxidantNO productionPreserves NO from oxidative degradation
Mechanism: Vitamin C helps regenerate tetrahydrobiopterin (BH4), an essential cofactor for eNOS. Without adequate BH4, eNOS becomes “uncoupled” and produces superoxide instead of NO.

Electrolytes + L-Citrulline

Electrolyte FunctionL-Citrulline FunctionCombined Benefit
Plasma volume maintenanceVasodilationOptimal fluid dynamics
Hydration supportBlood flow ↑Enhanced delivery

Why L-Citrulline in Sol (Not Luna)

FactorSol (Morning/Afternoon)Luna (Evening)
Timing alignment✓ Citrulline best AM/afternoon⚠️ Rare sleep sensitivity
Purpose fit✓ Cognitive performance, blood flow❌ Sleep induction
Mechanism relevance✓ Daytime cerebral circulation🤔 Less critical during sleep
Existing synergies✓ Creatine + Taurine❌ Glycine + Mg (sleep-focused)
Decision: L-Citrulline placed exclusively in Sol to align with daytime cognitive and cardiovascular support goals.

Why Kyowa Quality® L-Citrulline

FactorKyowa Quality®Generic
Purity≥99%Variable (95-99%)
ProductionFermentation-derivedMay be synthetic
ResearchUsed in majority of clinical trialsLimited traceability
TraceabilityFull supply chain documentationOften unclear
Non-GMOVerifiedVariable
GRASAffirmedMay lack dossier

Kyowa Hakko Bio

AttributeDetail
CompanyKyowa Hakko Bio Co., Ltd.
HeadquartersTokyo, Japan
SpecialtyAmino acid fermentation
History>60 years in amino acid production
Other branded ingredientsCognizin® (CDP-Choline), Sustamine® (L-Alanyl-L-Glutamine)

Manufacturing Process

Specifications

ParameterSpecification
Assay (L-Citrulline)≥99.0%
Specific rotation+18.0° to +20.5°
pH (1% solution)5.5-7.5
Loss on drying≤0.5%
Residue on ignition≤0.1%
Heavy metals≤10 ppm
Arsenic≤1 ppm
MicrobiologicalMeets USP standards

Alternative Consideration: Citrulline HCl

Recent research (2025) suggests citrulline hydrochloride may offer improved bioavailability:
ParameterL-CitrullineCitrulline HCl
Relative arginine bioavailabilityReference (100%)226%
Tmax120 min60 min
Urinary excretionHigherLower (better retention)
Consideration: Monitor citrulline HCl research; may become preferred form in future formulations.

When to Use L-Citrulline

ScenarioExpected BenefitProtocol
Daily cardiovascular supportModerate2g/day with Sol, ongoing
Blood pressure managementModerate-High3-6g/day, 6+ weeks
Pre-workout performanceModerate-High6-8g, 1 hour pre-exercise
Cognitive supportModerate2-3g/day, ongoing
Post-exercise recoveryModerate3-4g post-exercise

Realistic Expectations

TimeframeWhat to Expect
Acute (1-2 hours)Subtle; possibly warmth/flushing
Week 1Plasma arginine elevation established
Week 2-4Blood pressure changes may emerge
Week 6+Sustained vascular benefits
OngoingMaintained with continued use

Signs It’s Working

IndicatorDescription
Improved exercise toleranceReduced perceived exertion
Better recoveryLess muscle soreness
Blood pressure reductionMeasurable BP decrease
Improved “pump”During exercise (at higher doses)
Cognitive claritySubtle; improved focus

Administration Tips

TipRationale
Take in morning with SolAligns with NTRPX circadian protocol
Consistent daily useVascular benefits build over time
With or without foodNo significant absorption difference
Stay hydratedSupports blood flow and delivery
Avoid evening usePrevents rare sleep sensitivity
Higher doses separatelyFor performance, add pre-workout

Frequently Asked Questions

Yes, for oral supplementation. L-Citrulline has ~83% bioavailability versus ~20% for L-Arginine. L-Citrulline raises plasma arginine levels 2.5× more effectively than an equivalent dose of L-Arginine, with better GI tolerance. L-Arginine has largely been replaced by L-Citrulline in evidence-based formulations.
The 2g/day dose in Neuraldrink Sol provides maintenance-level cardiovascular and cerebrovascular support rather than acute performance enhancement. For significant exercise performance benefits (cycling time trials, high-intensity tolerance), studies typically use 6-8g/day. You can add additional L-Citrulline pre-workout for performance goals.
At 2g/day, the blood pressure reduction is modest (~4 mmHg SBP) and well-tolerated in most people. Those on antihypertensive medications or with low baseline blood pressure should monitor and consult their physician. The effect is generally beneficial, not dangerous.
L-Citrulline can be taken with or without food — absorption is not significantly affected. Taking it with Neuraldrink Sol (which may contain some carbohydrates) is perfectly fine.
Citrulline Malate contains only ~56% L-Citrulline (the rest is malic acid). While malic acid may have its own benefits for energy production, pure L-Citrulline allows for more precise dosing and a smaller powder volume. For Neuraldrink Sol, pure L-Citrulline is preferred.
Yes. L-Citrulline is GRAS (Generally Recognized As Safe) and has been studied in trials up to 16 weeks with no adverse effects. Doses up to 15g/day have been tested without safety concerns. L-Citrulline is a naturally occurring amino acid in the body and in foods like watermelon.
Caution is advised. Both L-Citrulline (via NO) and PDE5 inhibitors (sildenafil, tadalafil) cause vasodilation. Combining them may cause excessive blood pressure drop. Consult your physician before combining, or separate doses by several hours.
At typical doses, L-Citrulline does not affect sleep in most people. Rare anecdotal reports exist of sleep onset issues, possibly from improved blood flow. This is why NTRPX places L-Citrulline in Sol (morning) rather than Luna (evening).

Chemical Properties

PropertyValue
IUPAC name2-Amino-5-(carbamoylamino)pentanoic acid
CAS number372-75-8
Molecular formulaC₆H₁₃N₃O₃
Molecular weight175.19 g/mol
AppearanceWhite crystalline powder
SolubilityFreely soluble in water
TasteSlightly sweet, neutral
pKa2.43 (carboxyl), 9.41 (amino)

Structure

        O

H₂N—C—NH—(CH₂)₃—CH—COOH
                   |
                   NH₂

Etymology

TermOriginMeaning
CitrullineLatin CitrullusWatermelon (first isolated from watermelon in 1914)
L- prefixStereochemistryLevorotatory (naturally occurring form)

Metabolic Pathways

OTC = Ornithine Transcarbamylase; ASS = Argininosuccinate Synthase; ASL = Argininosuccinate Lyase; NOS = Nitric Oxide Synthase

Discovery Timeline

YearMilestone
1914L-Citrulline first isolated from watermelon
1930sRole in urea cycle discovered
1987Connection to NO synthesis established
1998Nobel Prize for NO signaling
2000sClinical trials for vascular/exercise benefits
2010sMeta-analyses confirm efficacy
2020sCerebrovascular research expands

FlowMax Summary: L-Citrulline (Kyowa Quality® 2,000 mg in Neuraldrink Sol) is the superior nitric oxide precursor for vascular and cerebrovascular health. With ~83% oral bioavailability versus ~20% for L-Arginine, L-Citrulline more than doubles plasma arginine levels at equivalent doses. Meta-analyses confirm significant blood pressure reductions (-4 mmHg SBP) and improved vascular function. L-Citrulline crosses the blood-brain barrier via LAT1 (187× higher expression than alternatives) to support cerebral blood flow and neurovascular coupling — the critical process linking neural activity to nutrient delivery. In Neuraldrink Sol, FlowMax™ L-Citrulline synergizes with creatine (energy production) and taurine (NO preservation) to optimize both what the brain needs and how it gets there. The 2,000 mg dose provides meaningful daily cardiovascular and cerebrovascular maintenance — not acute performance enhancement, but the foundation for sustained circulatory health.

Version: 1.0 | Last Updated: January 23, 2026 | Document Status: Complete Clinical MonographThis monograph establishes the L-Citrulline framework for NTRPX Systems. Kyowa Quality® L-Citrulline was selected based on purity (≥99%), fermentation-derived production, and use in the majority of published clinical trials. The 2,000 mg dose represents a meaningful maintenance level that fits within the Neuraldrink Sol powder format while synergizing with existing stack ingredients (creatine, taurine, electrolytes). Placement in Sol (morning) aligns with daytime cognitive and cardiovascular support goals while avoiding rare evening sleep sensitivity. L-Citrulline is placed exclusively in Sol (not Luna) due to purpose fit and timing alignment.